(Q70483062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference

S Yamasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

N Kan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T Harada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

Y Ichinose

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

Y Moriguchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

L Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T Sugie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

H Kodama

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

K Satoh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

K Ohgaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

55-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00682700

11 October 2019

exact match

0 references

cites work

Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma

1 reference

12 December 2020

Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients

1 reference

12 December 2020

Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma

1 reference

12 December 2020

Long term culture of tumour-specific cytotoxic T cells

1 reference

12 December 2020

Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

12 December 2020

Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract

1 reference

12 December 2020

Development of immunotherapeutic strategies for the treatment of malignant neoplasms

1 reference

12 December 2020

The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers

1 reference

12 December 2020

Clinical course of breast cancer patients with liver metastases

1 reference

12 December 2020

Immunotherapy and gene therapy of cancer

1 reference

12 December 2020

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients

1 reference

12 December 2020

[Specific anti-tumor immunity in pre- and postoperative state and 5-year survival of breast cancer patients]

1 reference

12 December 2020

Implications of potential positive correlation between autologous tumor-cell-killing activity and prognosis in lung cancer

1 reference

12 December 2020

[Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR]

1 reference

12 December 2020

Experimental anticancer studies. XXXI. On the streptococcal preparation having potent anticancer activity

1 reference

12 December 2020

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer

1 reference

12 December 2020

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

12 December 2020

Endocrine ablation and hepatic artery infusion in the treatment of metastases to the liver from carcinoma of the breast

1 reference

12 December 2020

Potentiation of adoptive immunotherapy by cis-diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden

1 reference

12 December 2020

Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy

1 reference

12 December 2020

Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00682700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400324%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference